189 related articles for article (PubMed ID: 16681048)
1. Vogt-Koyanagi-Harada disease in Thai patients.
Tesavibul N; Sansanayuth W
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Martin TD; Rathinam SR; Cunningham ET
Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada disease: clinical outcomes.
Bykhovskaya I; Thorne JE; Kempen JH; Dunn JP; Jabs DA
Am J Ophthalmol; 2005 Oct; 140(4):674-8. PubMed ID: 16226518
[TBL] [Abstract][Full Text] [Related]
4. [Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases].
Boutimzine N; Laghmari A; Ouazzani I; Ibrahimy W; Mohcine Z
J Fr Ophtalmol; 1998 Dec; 21(10):746-54. PubMed ID: 10052048
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
Chee SP; Jap A; Bacsal K
Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
Paredes I; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
[TBL] [Abstract][Full Text] [Related]
7. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
[TBL] [Abstract][Full Text] [Related]
8. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Agarwal M; Ganesh SK; Biswas J
Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
[TBL] [Abstract][Full Text] [Related]
9. Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories.
da Silva FT; Damico FM; Marin ML; Goldberg AC; Hirata CE; Takiuti PH; Olivalves E; Yamamoto JH
Am J Ophthalmol; 2009 Feb; 147(2):339-345.e5. PubMed ID: 18992868
[TBL] [Abstract][Full Text] [Related]
10. Vogt-Koyanagi-Harada disease in children.
Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
[TBL] [Abstract][Full Text] [Related]
11. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
Bouchenaki N; Morisod L; Herbort CP
Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
Fang W; Zhou H; Yang P; Huang X; Wang L; Kijlstra A
Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
[TBL] [Abstract][Full Text] [Related]
13. [Vogt-Koyanagi-Harada disease].
Kjeka O; Krohn J
Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
Read RW; Yu F; Accorinti M; Bodaghi B; Chee SP; Fardeau C; Goto H; Holland GN; Kawashima H; Kojima E; Lehoang P; Lemaitre C; Okada AA; Pivetti-Pezzi P; Secchi A; See RF; Tabbara KF; Usui M; Rao NA
Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
[TBL] [Abstract][Full Text] [Related]
16. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
Chee SP; Jap A
Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
[TBL] [Abstract][Full Text] [Related]
17. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
18. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
Lai TY; Chan RP; Chan CK; Lam DS
Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
[TBL] [Abstract][Full Text] [Related]
19. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
[TBL] [Abstract][Full Text] [Related]
20. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
Nazari H; Rao NA
Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]